Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Bayer and Zeneca to comarket Ca antagonist

Feb. 26, 1997

Adenosine antagonists claimed by Fujisawa

Feb. 26, 1997

Unexpected phase I results reported for DuP-532

Feb. 25, 1997

Deltibant in SIRS

Feb. 21, 1997

Cylexin enters clinical trials in newborns

Feb. 21, 1997

Novel vasopressin antagonists from Fujisawa

Feb. 21, 1997

Biorex discloses antiischemic agents

Feb. 20, 1997

Zambon discloses ACE/NEP inhibitors

Feb. 20, 1997

Antiarrhythmic agents from Merck & Co.

Feb. 19, 1997

German launch for ACE inhibitor

Feb. 17, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...